OBI Pharma’s Board of Directors approves the announcement of the Company’s 2016 individual and consolidated financial statementsMarch 9, 2017
The board of directors have resolved not to distribute dividendsMarch 9, 2017
- Date of the board of directors resolution: Thursday 9 March 2017
Date for convening the shareholders’ meeting: Wednesday 28 June 2017
Location for convening the shareholders’ meeting: 11F., #97, Dunhua S. Road, Sec. 2, Da’an District, Taipei City 106, TAIWAN (ROC)
Purpose or subjects for convening the meeting
A. 2016 Business Report
B. 2016 Audit Committee’s Report
C. Report on Execution Status of the Improvement Plan of the Operation of the Company
D. Amendment to the Employee Stock Option Plan
(2)Matters for Ratification:
A. Adoption of the 2016 Business Report and Financial Statements.
B. Adoption of the Proposal for 2016 Deficit Compensation.
(3)Matters for Discussion: Amendment to the Operational Procedures for Acquisition and Disposal of Assets of the Company.
(5)Other Proposals: None
(6)Extemporary Motions: None.
Book closure starting date: 30 April 2017
Book closure ending date: 28 June 2017
Any other matters that need to be specified: According to Article 172-1 of Taiwan’s Company Act, if shareholders with over 1% holdings would like to make a proposal at the shareholders’ meeting, the Company will accept such propositions from 17 April 2017 to 27 April 2017. Please note shareholder(s)’s account name and full contact details must be submitted for our screening in advance. (Kindly write “Proposal for 2016 Annual General Meeting of Shareholders” on the envelope and send by registered mail to the company before 5:00 pm 27 April 2016. The address for receiving proposals: OBI Pharma, Inc. 7F, #369, Zhongxiao E. Road, Sec 7, Nangang Distict, Taipei City, ROC TEL: +886-2-27866589 ext.199/155). Shareholders may exercise their voting rights via electronic transmission by logging in to the TDCC website to vote from 29 May 2017 to 25 June 2017 www.stockvote.com.tw